Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouzahzah, B.
Right arrow Articles by Pestell, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouzahzah, B.
Right arrow Articles by Pestell, R. G.
[Cancer Research 60, 4531-4537, August 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Transforming Growth Factor-ß1 Recruits Histone Deacetylase 1 to a p130 Repressor Complex in Transgenic Mice in Vivo1

Boumediene Bouzahzah, Maofu Fu, Antonio Iavarone, Valentina M. Factor, Snorri S. Thorgeirsson and Richard G. Pestell2

The Albert Einstein Cancer Center, Departments of Developmental and Molecular Biology [B. B., M. F., A. I., R. G. P.], Medicine [A. I., R. G. P.], and Neurology [A. I.], Albert Einstein College of Medicine, Bronx, New York 10461, and Laboratory of Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [V. M. F., S. S. T.]

Transforming growth factor (TGF)-ß1 functions as a tumor suppressor in vivo. Using transgenic mice, we show that hepatic TGF-ß1 overexpression inhibits abundance of the cyclin-dependent kinase activating tyrosine phosphatase cdc25A protein. The reduction in cdc25A protein levels was associated with increased binding of histone deacetylase 1 to p130 in the hepatic extracts. In cultured cells, HDAC1/p130 overexpression inhibited activity of the cdc25A promoter through an E2F site. TGF-ß1 treatment enhanced p130 binding to the cdc25A promoter E2F site assessed in chromatin immunoprecipitation assays. Hepatic proliferation induced by partial hepatectomy was associated with a decrease in the amount of HDAC1 bound to p130, without a significant decrease in p130 abundance, suggesting that HDAC1 binding to p130 may be regulated by proliferative stimuli. The induction of cdc25A abundance induced by partial hepatectomy correlated with the induction of DNA synthesis. These studies suggest that TGF-ß1 may enhance HDAC1 binding to p130 in vivo, thereby inhibiting cdc25A gene expression. TGF-ß1 regulation of HDAC1/pocket protein associations may provide a link between chromatin remodeling proteins and cdk inhibition through induction of cdc25A in vivo.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, X. Zhang, Z. Li, T.-P. Yao, and R. G. Pestell
Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor {gamma}-mediated Adipogenesis through Histone Deacetylase Recruitment
J. Biol. Chem., April 29, 2005; 280(17): 16934 - 16941.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. McKarns, R. H. Schwartz, and N. E. Kaminski
Smad3 Is Essential for TGF-{beta}1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation
J. Immunol., April 1, 2004; 172(7): 4275 - 4284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Haller, L. Holt, S. C. Kim, R. F. Schwabe, R. B. Sartor, and C. Jobin
Transforming Growth Factor-{beta}1 Inhibits Non-pathogenic Gramnegative Bacteria-induced NF-{kappa}B Recruitment to the Interleukin-6 Gene Promoter in Intestinal Epithelial Cells through Modulation of Histone Acetylation
J. Biol. Chem., June 20, 2003; 278(26): 23851 - 23860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Strieder and W. Lutz
E2F Proteins Regulate MYCN Expression in Neuroblastomas
J. Biol. Chem., January 24, 2003; 278(5): 2983 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Macias-Silva, W. Li, J. I. Leu, M. A. S. Crissey, and R. Taub
Up-regulated Transcriptional Repressors SnoN and Ski Bind Smad Proteins to Antagonize Transforming Growth Factor-beta Signals during Liver Regeneration
J. Biol. Chem., August 2, 2002; 277(32): 28483 - 28490.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Wu, C. Wang, M. D'Amico, R. J. Lee, C. Albanese, R. G. Pestell, and S. Mani
Flavopiridol and Trastuzumab Synergistically Inhibit Proliferation of Breast Cancer Cells: Association with Selective Cooperative Inhibition of Cyclin D1-dependent Kinase and Akt Signaling Pathways
Mol. Cancer Ther., July 1, 2002; 1(9): 695 - 706.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Fu, C. Wang, J. Wang, X. Zhang, T. Sakamaki, Y. G. Yeung, C. Chang, T. Hopp, S. A. W. Fuqua, E. Jaffray, et al.
Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function
Mol. Cell. Biol., May 15, 2002; 22(10): 3373 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. J. P. L. Kops, R. H. Medema, J. Glassford, M. A. G. Essers, P. F. Dijkers, P. J. Coffer, E. W.-F. Lam, and B. M. T. Burgering
Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors
Mol. Cell. Biol., April 1, 2002; 22(7): 2025 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. X. Nguyen, T. F. Westbrook, and D. J. McCance
Human Papillomavirus Type 16 E7 Maintains Elevated Levels of the cdc25A Tyrosine Phosphatase during Deregulation of Cell Cycle Arrest
J. Virol., January 15, 2002; 76(2): 619 - 632.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. T. Reutens, M. Fu, C. Wang, C. Albanese, M. J. McPhaul, Z. Sun, S. P. Balk, O. A. Jänne, J. J. Palvimo, and R. G. Pestell
Cyclin D1 Binds the Androgen Receptor and Regulates Hormone-Dependent Signaling in a p300/CBP-Associated Factor (P/CAF)-Dependent Manner
Mol. Endocrinol., May 1, 2001; 15(5): 797 - 811.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.